Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Apremilast, ATC L04AA32 für die Zeit 01.01.2025 - 31.12.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- Amgen GmbH
- Contract value
- no value published
- Bids received
- 3
- Published
- 28 Jan 2026
- Awarded
- 1 Jan 2025
- Contract start
- 1 Jan 2025
- Contract end
- 14 Jan 2026estimated
- Region
- Hamburg